Nuvation Bio Inc. (NUVB)

Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	7.87	-	-	-	-
Cost of Revenue	7.08	-	-	-	-
Gross Profit	0.8	-	-	-	-
Selling, General & Admin	69.23	28.53	31.92	24.28	10.95
Research & Development	99.12	71.29	87.82	65.25	32.6
Operating Expenses	168.35	99.82	119.73	89.53	43.55
Operating Income	-167.56	-99.82	-119.73	-89.53	-43.55
Interest Expense	-0.34	-	-	-	-
Interest & Investment Income	27.06	24.61	7.45	2.96	1.95
Other Non Operating Income (Expenses)	-2.02	-0.45	9.32	3.59	-0.27
EBT Excluding Unusual Items	-142.86	-75.66	-102.97	-82.98	-41.88
Gain (Loss) on Sale of Investments	-0.01	-0.14	-1.23	-0.08	0.22
Pretax Income	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income to Common	-567.94	-75.8	-104.2	-86.85	-41.66
Shares Outstanding (Basic)	269	219	217	198	98
Shares Outstanding (Diluted)	269	219	217	198	98
Shares Change (YoY)	22.79%	1.00%	9.52%	102.90%	-52.81%
EPS (Basic)	-2.11	-0.35	-0.48	-0.44	-0.43
EPS (Diluted)	-2.11	-0.35	-0.48	-0.44	-0.43
Free Cash Flow	-130.58	-68.07	-96.48	-68.47	-36.67
Free Cash Flow Per Share	-0.49	-0.31	-0.45	-0.35	-0.38
Gross Margin	10.10%	-	-	-	-
Operating Margin	-2128.25%	-	-	-	-
Profit Margin	-7213.76%	-	-	-	-
Free Cash Flow Margin	-1658.52%	-	-	-	-
EBITDA	-166.87	-99.6	-119.54	-89.35	-43.45
D&A For EBITDA	0.68	0.22	0.2	0.18	0.1
EBIT	-167.56	-99.82	-119.73	-89.53	-43.55

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q